$AMLX

$27.09 -$0.11 (0.4%) Close

$AMLX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$AMLX Management Team

Mr. Justin Klee

Co-Chief Executive Officer

Director

Age 34

Compensation $6.496M USD

Sex Male

Mr. James Frates

Chief Financial Officer

Age 57

Compensation $2.540M USD

Sex Male

Ms. Gina Mazzariello

Chief Legal Officer and General Counsel

Age 53

Compensation $2.299M USD

Sex Female

Ms. Lindsey Allen

IR Contact Officer

Age -

Compensation -

Sex Female

Mr. Joshua Cohen

Co-Chief Executive Officer

Director

Age 33

Compensation $6.496M USD

Sex Male

Dr. Camille Bedrosian

Chief Medical Officer

Age 72

Compensation $2.373M USD

Sex Female

Name / Title	Age	Compensation	Sex
Mr. Justin Klee Co-Chief Executive Officer Director	34	$6.496M USD	Male
Mr. James Frates Chief Financial Officer	57	$2.540M USD	Male
Ms. Gina Mazzariello Chief Legal Officer and General Counsel	53	$2.299M USD	Female
Ms. Lindsey Allen IR Contact Officer	-	-	Female
Mr. Joshua Cohen Co-Chief Executive Officer Director	33	$6.496M USD	Male
Dr. Camille Bedrosian Chief Medical Officer	72	$2.373M USD	Female

Board of Directors

From the proxy statement filed Apr 23, 2026

Directors

serving now

Independent

Not stated

the proxy does not say

Average tenure

7.1 years

from year joined

CEO also chairs the board

George Mclean Milne Jr., Ph.D.

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
George Mclean Milne Jr., Ph.D. Board chair	82	2015 11 years	Not stated	None stated	None stated	$218,578
Paul Fonteyne	64	2021 5 years	Not stated	None stated	None stated	$168,578
Joshua Cohen CEO	34	2014 12 years	Not stated	None stated	None stated	Paid as CEO
Daphne Quimi	60	2021 5 years	Not stated	audit · Chair	Century Therapeutics, Inc. (Nasdaq: IPSC)	$173,578
Justin Klee CEO	35	2014 12 years	Not stated	None stated	None stated	Paid as CEO
Karen Firestone	70	2023 3 years	Not stated	nominating and corporate governance	None stated	$161,078
Bernhardt Zeiher, M.D.	62	2024 2 years	Not stated	science and technology · Chair	Entrada Therapeutics, Inc. (Nasdaq: TRDA), Abeona Therapeutics Inc. (Nasdaq: ABEO)	$166,078

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$AMLX Management Team

Mr. Justin Klee

Mr. James Frates

Ms. Gina Mazzariello

Ms. Lindsey Allen

Mr. Joshua Cohen

Dr. Camille Bedrosian

Board of Directors

Related-party transactions

No related-party transactions disclosed